$FOGC Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board

Jun 18, 2014 at 4:33 PM

$FOGC Up to date company activities and other important information about $FOGC

$FOGC

DD Notes ~ http://www.ddnotesmaker.com/FOGC

##### recent news/filings ~ source: finance.yahoo.com

Wed, 18 Jun 2014 17:04:07 GMT ~ FORTUNE OIL & GAS INC Financials
read full: http://finance.yahoo.com/q/is?s=fogc
*********************************************************

Tue, 17 Jun 2014 20:01:00 GMT ~ Manzo Pharmaceuticals announces the release of its newest product Tummy Relief a natural colic remedy for babies
- MILFORD, Pa., June 17, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that its wholly owned subsidiary, Manzo Pharmaceuticals has released its first retail product to be available to the public. It is a remedy for babies with excess gas, which often causes a condition known as colic. The product, called Manzo's Tummy Relief, is currently available for purchase on Amazon.com. Colic is defined as periods of continuous crying for more than three hours per day, and although many other ailments can cause the condition, stomach and intestinal gas is often the culprit. Manzo's solution is a natural, safe and effective liquid given to the infant in the form of drops. Compared to competitors, Manzo's solution contains larger amounts of the effective ingredients, costs less, does not contain many unnatural or even harmful additives that other remedies do, and it comes in a unique spill proof bottle that avoids those frustrating spills and allows for more efficient use of the product with less waste. With competitor's products, it is difficult to get all of the liquid out of the bottle because of the design of the packaging causing waste, and costing consumers more money, but with Manzo's design, consumers can use every last drop in the bottle saving time and money.
read full: http://finance.yahoo.com/news/manzo-pharmaceu...00467.html
*********************************************************

Mon, 16 Jun 2014 12:00:00 GMT ~ Manzo Pharmaceuticals starts laboratory testing of its lactose intolerance probiotic treatment
- MILFORD, Pa., June 16, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that the company's wholly owned subsidiary, Manzo Pharmaceuticals has begun a series of laboratory testing for its patented probiotic formula, Lacto-Freedom™. Lacto-Freedom™ is designed to stop the symptoms of lactose intolerance for up to several months after taking it for just a short time. The company started a six month long study with different dosages of the probiotic to find the optimum amount needed to achieve the desired effect. The safety of the product will also be confirmed over the course of this study and will prepare the product for human clinical trials. A stability test may also be performed to determine the best way to store the product and which dosage form is best (liquid, capsule, freeze dried powder, or pre-mixed in food) this study will bring Manzo Pharmaceuticals one-step closer to making this unique treatment available to the people who need it.
read full: http://finance.yahoo.com/news/manzo-pharmaceu...00680.html
*********************************************************

Wed, 11 Jun 2014 20:01:00 GMT ~ Fortune Oil & Gas announces major change in business direction with the acquisition of Manzo Pharmaceuticals
- MILFORD, Pa., June 11, 2014 /PRNewswire/ -- Fortune Oil & Gas, Inc. (FOGC), today announced that the company has acquired Manzo Pharmaceuticals, LLC., a private firm aiming to become a major force in the pharmaceutical industry. As part of the acquisition, Manzo Pharmaceutical's founder and President, Kenneth Manzo has been appointed CEO and Chairman of Fortune Oil & Gas, Inc. Manzo Pharmaceuticals, LLC is a specialty pharmaceutical company that is currently developing a range of innovative and affordable formulations for various drugs and supplements with innovative, patient-friendly and affordable solutions. The company's new CEO, Kenneth Manzo, is a licensed Pharmacist with 25 years of experience in the pharmaceutical industry.
read full: http://finance.yahoo.com/news/fortune-oil-gas...00512.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=FOGC&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=FOGC&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/FOGC/company-info
Ticker: $FOGC
OTC Market Place: OTC Pink Current
CIK code: 0001119949
Company name: Fortune Oil & Gas, Inc.
Company website: http://manzopharma.com
Incorporated In: WY, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/FOGC/filings
Latest financials: http://www.otcmarkets.com/stock/FOGC/financials
Latest news: http://www.otcmarkets.com/stock/FOGC/news - http://finance.yahoo.com/q/h?s=FOGC+Headlines

Major holdings: http://data.cnbc.com/quotes/FOGC/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=FOGC+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/FOGC.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=FOGC

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Fortune+Oil+%26+Ga...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...Gas%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://manzopharma.com
Alexa: http://www.alexa.com/siteinfo/http://manzopharma.com#
Corporate website internet archive: http://web.archive.org/web/*/http://manzopharma.com

Short Sales: http://www.otcmarkets.com/stock/FOGC/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/FOGC/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/FOGC/research
Historical Prices: http://finance.yahoo.com/q/hp?s=FOGC+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=FOGC+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=FOGC+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=FOGC+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=FOGC+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=FOGC+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=FOGC
Balance Sheet: http://finance.yahoo.com/q/bs?s=FOGC
Cash Flow: http://finance.yahoo.com/q/cf?s=FOGC+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/FOGC
Bloomberg: http://www.bloomberg.com/quote/FOGC:US
Morningstar: http://quotes.morningstar.com/stock/s?t=FOGC
Bussinessweek: http://investing.businessweek.com/research/st...icker=FOGC
Barchart: http://www.barchart.com/quotes/stocks/FOGC
OTC Short Report: http://otcshortreport.com/index.php?index=FOGC
Investopedia: http://www.investopedia.com/markets/stocks/FOGC/?wa=0

http://www.pennystocktweets.com/stocks/profile/FOGC

##### last known share structure ~ source: otcmarkets.com

Market Value: $2,416,691 a/o Jun 17, 2014
Shares Outstanding: 2,685,211,678 a/o Jun 05, 2014
Float: 2,498,858,639 a/o Jun 05, 2014
Authorized Shares: 5,000,000,000 a/o Jun 05, 2014
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Fortune Oil & Gas, Inc. is an Oil & Gas company that recently acquired Manzo Pharmaceuticals, LLC. This new wholly owned subsidiary is a specialty pharmaceutical company that is developing a range of innovative and affordable formulations for various drugs and supplements. Manzo Pharmaceuticals is focused on addressing the unmet medical needs of patients with innovative, patient-friendly and affordable solutions. Manzo Pharmaceuticals is currently engaged in research and development of a patented new experimental product that will help people with lactose intolerance by removing the symptoms for months at a time after taking it only for a short time. Other products include a safe and natural solution for babies with colic, gas, and stomach discomfort that will be released for sale to the public very shortly.Less >>

DD Notes ~ http://www.ddnotesmaker.com/FOGC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DIR Launches ManhattanHockey.com Amid Rangers' 100th Year

Digital Information Makes a Bold Play in Sports Media The puck drops in a whole new way today as Digital Information Resources (DIR) decides it's the digital age for hockey. They've tossed their hat into the rink, launching ManhattanHockey.com, wholeheartedly dedicated to fans of the New York Rangers. The timing's no fluke—this year marks the century milestone for the...

AAN Seeks Donations to Drive Crucial Brain Research

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

NetEase Awaits Q3 2026 Results: What's at Stake?

D-Day for NetEase: Quarterly Results Incoming We're inching closer to November 19, 2026, and if you hold a piece of NetEase (NASDAQ: NTES), you're probably on pins and needles. This is when the curtains rise on their third-quarter financial results, which they've been fiercely guarding like a high-stakes poker hand. They'll be laying it all out right before the U.S....

Sysco's Regulatory Hurdle: Investors Eye Jetro Deal Risks

Sysco's Tumultuous Day: A Sharp Dive Well, folks, if you're holding onto Sysco shares, you might be feeling the pinch. On November 3, 2026, Sysco Corporation (NYSE: SYY) took a nosedive, dropping 9.3% in a single trading session. The reason? A hefty $29.1 billion acquisition deal that's still caught up in regulatory limbo. The looming merger with Jetro Restaurant Depot...

Sharon Bowen Honored; e.l.f. Beauty Hits 31 Quarters

Markets Stir as NYSE Chair Earns Lifetime Award While the financial world often gets lost in numbers, sometimes it's the people who stand out. NYSE Chair Sharon Bowen is taking the spotlight with her lifetime achievement award, underscoring her game-changing influence in governance. This is more than just a pat on the back; it's a nod to the force she’s been in steering...

Preplanning Funerals: Choices for Clarity and Comfort

Making Clear Plans for the Inevitable Man, if life is certain about one thing, it’s the endgame. And nobody wants to pass the buck on sorting out the details when they’re six feet under. Enter funeral preplanning – a chance to write the script for your own final episode and keep your family out of the weeds when the time comes. Jake Leonetti over at Stone Chapel...

Ryde Group Faces Fraud Claims: Investor Action Looms

Big Trouble in the Stock Market for Ryde Group Well, hold onto your hats, folks—Ryde Group Ltd. is neck-deep in legal hot water. If you thought the stock market was a place of pure strategy and devoid of any drama, think again. Recently, DJS Law Group threw down the gauntlet with a class action lawsuit against Ryde Group (NYSE American: RYDE) for some pretty hefty...

Hidden Costs of Lineworker and CDL Training in California

The True Financial Picture of Skilled Trade Programs Ever wonder why that flashy tuition number doesn't line up with your wallet by the end of your training days? That's the reality smashing aspiring lineworkers and future truck drivers in Northern California right in the face. We're talking about a full breakdown here, beyond what the glossy brochures ever tell you....

Manulife's Q3 2026: Strong Gains Amid Income Dip

Manulife's Resilience in a Volatile Market Trading has a way of keeping folks on their toes. Just when you think you've ridden the bull long enough, it tries bucking you off. That's how it goes for Manulife Financial Corporation (TSX/NYSE/PSE: MFC), as they reported their Q3 2026 results—marking a seesaw of gains and losses. Core Earnings Shine While Net Income Declines...

Bram Schot Steers Marelli Through Chapter 11 Resurgence

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...